Appili Therapeutics Is A Canadian Biopharmaceutical Company Dedicated To Addressing Global Challenges In Infectious Diseases And Biodefensethe Company Focuses On Developing Innovative Drug Programs To Meet Unmet Patient Needs Across A Wide Range Of Infectious Diseasesappili Therapeutics Employs A Strategy That Includes Both Internal Innovation And Active In Licensing To Advance Its Drug Development Efforts The Company S Key Pipeline Programs Include Ati 1801 And Ati 1701With Ati 1701 Preparing For An Investigational New Drug Submissionappili Therapeutics Emphasizes Strong Partnerships With Government Entities And Engages With Regulatory Authorities To Enhance Its Position In The Fieldled By Drdon Cillathe Company Is Committed To Accelerating The Development Of Critical Treatments For Infectious Diseasessupported By Funding From Various Investors
